Skip to main content
. Author manuscript; available in PMC: 2013 Sep 8.
Published in final edited form as: Proteomics. 2012 Apr;12(8):1244–1252. doi: 10.1002/pmic.201100601

Figure 4.

Figure 4

SRM data of serum A1BG and CFH levels in both patients DJ001705 and DJ001652 (arrows) are of good quality; their relative protein levels are probably truly different from other patients. However, this discrepancy can be resolved by examining simultaneously A1BG and CFH or A1BG and IGFALS levels in these patients (4A). A combination of A1BG, CFH and IGFALS is able to discriminate healthy controls from HCV patients from Ishak scores 2 to 6 with predicted high sensitivity and specificity (4B).